<DOC>
	<DOCNO>NCT00403585</DOCNO>
	<brief_summary>This open label , single-arm , multi-centre extension study Korean patient chronic hepatitis B compensate liver disease complete one-year adefovir dipivoxil treatment ADF103814 . The objective ass clinical efficacy safety long term ( 3 year ) adefovir dipivoxil 10mg therapy .</brief_summary>
	<brief_title>Study Adefovir Dipivoxil Korean Patients With Chronic Hepatitis B ( CHB ) Who Have Completed ADF 103814</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<criteria>Subject complete ADF103814 continue adefovir dipivoxil treatment via prescription without interruption prior enrolment extension study . Availability willingness subject provide write informed consent . Use immunosuppressive therapy require use 5mg prednisolone ( equivalent ) per day , immunomodulatory therapy ( include interferon thymosin ) systemic cytotoxic agent study . Previous current lamivudine antiviral therapy Clinical sign decompensated liver disease indicate protocol Inadequate haematological function define protocol Documented evidence active liver disease due cause Hepatocellular carcinoma evidence protocol Any serious active medical psychiatric illness hepatitis B , opinion investigator , would interfere patient treatment , assessment compliance protocol . This would include uncontrolled clinically significant renal , cardiac , pulmonary , vascular , neurogenic , digestive , metabolic ( diabetes , thyroid disorder , adrenal disease ) , immunodeficiency disorder cancer . Active alcohol drug abuse history alcohol drug abuse consider investigator sufficient hinder compliance treatment , participation study interpretation result . Planned liver transplantation Therapy nephrotoxic drug competitor renal excretion expect course study . History hypersensitivity nucleoside and/or nucleotide analogue . Inability comply study requirement determine study investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Adefovir Dipivoxil ( Hepsera )</keyword>
	<keyword>Chronic Hepatitis B ( CHB )</keyword>
</DOC>